Nutrinia Ltd., USA Office

https://www.nutrinia.com

Nutrinia, Ltd. is a clinical stage biotechnology company focused on developing a proprietary oral formulation of insulin for gastrointestinal indications in infants. Insulin has been shown to induce a receptor-mediated response leading to gut maturation and adaptation, important in preterm newborns with intestinal malabsorption and infants similarly affected by Short Bowel Syndrome. There are no approved therapies for either of these orphan conditions. Nutrinia’s unique oral formulation of insulin is locally acting, and stable at room temperature, rapidly dissolving into saline, formula or breast milk, and designed for administration through the plastic tubing used in enteral feeding as well as simply orally. The Company has shown efficacy and safety in animal studies and multiple human clinical trials. Nutrinia is headquartered in Ramat-Gan, Israel, with its US operations based out of Morristown, NJ. *

	Start	2016-08-18 existent
	Group	Nutrinia (Group)
	Industry	BIOTECH
	Industry 2	insulin

	Region	Ramat Gan
	Country	Israel
	Street	89 Headquarters Plaza
	City	07960 Morristown, NJ
	Tel	+1-973-867-7766
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]